Healthcare provider profile · identity verified

Mario Fuentes, M.D

General Practice · MIAMI, FL · NPI 1659798668

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	950	265
Metoprolol Succinate	Metoprolol Succinate	880	110
Amlodipine Besylate	Amlodipine Besylate	806	111
Omeprazole	Omeprazole	752	91
Gabapentin	Gabapentin	648	71
Diclofenac Sodium	Diclofenac Sodium	634	133
Jardiance	Empagliflozin	614	71
Hydrochlorothiazide	Hydrochlorothiazide	536	73
Alendronate Sodium	Alendronate Sodium	522	70
Famotidine	Famotidine	510	60
Losartan Potassium	Losartan Potassium	490	120
Rosuvastatin Calcium	Rosuvastatin Calcium	477	139
Levothyroxine Sodium	Levothyroxine Sodium	447	62
Pantoprazole Sodium	Pantoprazole Sodium	375	51
Metformin Hcl	Metformin Hcl	360	93
Furosemide	Furosemide	354	45
Alcohol Prep Pads	Alcohol Antiseptic Pads	330	51
Montelukast Sodium	Montelukast Sodium	326	36
Chlorthalidone	Chlorthalidone	313	43
Tamsulosin Hcl	Tamsulosin Hcl	294	49
Lisinopril	Lisinopril	290	81
Donepezil Hcl	Donepezil Hcl	272	33
Eliquis	Apixaban	266	35
Ciclopirox	Ciclopirox	250	37
Metoprolol Tartrate	Metoprolol Tartrate	235	32
Ezetimibe	Ezetimibe	203	28
Clopidogrel	Clopidogrel Bisulfate	190	28
Rybelsus	Semaglutide	188	29
Albuterol Sulfate Hfa	Albuterol Sulfate	184	27
Trazodone Hcl	Trazodone Hcl	166	27
Fluticasone Propionate	Fluticasone Propionate	164	47
Linzess	Linaclotide	160	22
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	155	35
Ketoconazole	Ketoconazole	152	20
Hydrocortisone	Hydrocortisone	146	22
Ozempic	Semaglutide	144	19
Vitamin D2	Ergocalciferol (Vitamin D2)	142	39
Memantine Hcl	Memantine Hcl	133	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	121	18
Finasteride	Finasteride	119	14
Sildenafil Citrate	Sildenafil Citrate	118	18
Carvedilol	Carvedilol	116	21
Bumetanide	Bumetanide	112	15
Entresto	Sacubitril/Valsartan	108	15
Escitalopram Oxalate	Escitalopram Oxalate	107	15
Atenolol	Atenolol	104	14
Citalopram Hbr	Citalopram Hydrobromide	101	suppressed
Farxiga	Dapagliflozin Propanediol	101	14
Mometasone Furoate	Mometasone Furoate	100	29
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	98	17
Mirtazapine	Mirtazapine	98	12
Sertraline Hcl	Sertraline Hcl	93	11
Symbicort	Budesonide/Formoterol Fumarate	88	14
Ammonium Lactate	Ammonium Lactate	82	16
Spironolactone	Spironolactone	78	suppressed
Azithromycin	Azithromycin	75	65
Enalapril Maleate	Enalapril Maleate	75	20
Allopurinol	Allopurinol	74	suppressed
Glipizide Er	Glipizide	71	18
Ibuprofen	Ibuprofen	71	53
Amiodarone Hcl	Amiodarone Hcl	70	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	64	suppressed
Mupirocin	Mupirocin	64	36
Duloxetine Hcl	Duloxetine Hcl	61	13
Prednisone	Prednisone	58	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	56	14
Telmisartan	Telmisartan	55	14
Xarelto	Rivaroxaban	55	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	52	suppressed
Synthroid	Levothyroxine Sodium	52	suppressed
Vascepa	Icosapent Ethyl	52	suppressed
Clonidine Hcl	Clonidine Hcl	49	suppressed
Hydralazine Hcl	Hydralazine Hcl	49	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	48	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	46	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	45	15
Lactulose	Lactulose	43	suppressed
Pravastatin Sodium	Pravastatin Sodium	43	12
Triamcinolone Acetonide	Triamcinolone Acetonide	43	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	43	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	42	suppressed
Potassium Chloride	Potassium Chloride	42	suppressed
Clobetasol Propionate	Clobetasol Propionate	40	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	39	13
Glipizide	Glipizide	35	11
Azelastine Hcl	Azelastine Hcl	34	11
Esomeprazole Magnesium	Esomeprazole Magnesium	34	suppressed
Sucralfate	Sucralfate	34	suppressed
Irbesartan	Irbesartan	33	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	32	28
Digoxin	Digoxin	32	suppressed
Latanoprost	Latanoprost	32	suppressed
Nitroglycerin	Nitroglycerin	32	suppressed
Novolog Flexpen	Insulin Aspart	32	suppressed
Trueplus Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	32	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	31	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	31	suppressed
Cromolyn Sodium	Cromolyn Sodium	30	suppressed
Nifedipine Er	Nifedipine	29	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	28	suppressed
Simvastatin	Simvastatin	28	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	27	suppressed
Cefdinir	Cefdinir	26	22
Creon	Lipase/Protease/Amylase	26	suppressed
Pentoxifylline	Pentoxifylline	26	suppressed
Glimepiride	Glimepiride	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	22
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	23	suppressed
Indapamide	Indapamide	23	suppressed
Torsemide	Torsemide	23	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	23	suppressed
Breyna	Budesonide/Formoterol Fumarate	22	12
Carbidopa-Levodopa	Carbidopa/Levodopa	22	suppressed
Naproxen	Naproxen	22	17
Tadalafil	Tadalafil	22	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Lansoprazole	Lansoprazole	18	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	18	suppressed
Valsartan	Valsartan	18	suppressed
Fenofibrate	Fenofibrate,micronized	17	suppressed
Levofloxacin	Levofloxacin	17	13
Midodrine Hcl	Midodrine Hcl	17	suppressed
Cilostazol	Cilostazol	16	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	16	15
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Primidone	Primidone	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Ciclopirox	Ciclopirox Olamine	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Felodipine Er	Felodipine	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Potassium Citrate Er	Potassium Citrate	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Verapamil Hcl	Verapamil Hcl	15	suppressed
Fiasp	Insulin Aspart (Niacinamide)	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Hydroxyurea	Hydroxyurea	14	suppressed
Ibandronate Sodium	Ibandronate Sodium	14	suppressed
Multaq	Dronedarone Hcl	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Zenpep	Lipase/Protease/Amylase	14	suppressed
Benzonatate	Benzonatate	13	suppressed
Nexletol	Bempedoic Acid	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Fluconazole	Fluconazole	12	12
Fluocinolone Acetonide	Fluocinolone Acetonide	12	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	12	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	11
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Cephalexin	Cephalexin	11	suppressed
Dapagliflozin	Dapagliflozin Propanediol	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Galantamine Hbr	Galantamine Hbr	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error